Filing Details
- Accession Number:
- 0001104659-23-105925
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-10-02 16:39:08
- Reporting Period:
- 2023-09-28
- Accepted Time:
- 2023-10-02 16:39:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1829635 | Transcode Therapeutics Inc. | RNAZ | Pharmaceutical Preparations (2834) | 811065054 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1854168 | A Thomas Fitzgerald | C/O Transcode Therapeutics, Inc. 6 Liberty Square, #2382 Boston MA 02109 | Chief Financial Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-09-28 | 49,350 | $0.51 | 56,318 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents shares acquired pursuant to an underwritten public offering of common stock by the Issuer.
- Reported amount reflects a 1-for-20 reverse stock split of the Issuer's common stock, which became effective as of May 22, 2023.
Billionaire Hedge Funds
